Mazama Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-11,139
| Closed | -$701K | – | 297 |
|
|
2015
Q2 | $701K | Sell |
11,139
-23,136
| -68% | -$1.46M | 0.14% | 152 |
|
|
2015
Q1 | $1.65M | Sell |
34,275
-43,889
| -56% | -$2.11M | 0.34% | 89 |
|
|
2014
Q4 | $2.6M | Buy |
78,164
+55,352
| +243% | +$1.84M | 0.6% | 56 |
|
|
2014
Q3 | $669K | Buy |
22,812
+11,354
| +99% | +$333K | 0.17% | 154 |
|
|
2014
Q2 | $445K | Buy |
11,458
+9,815
| +597% | +$381K | 0.12% | 184 |
|
|
2014
Q1 | $69K | Sell |
1,643
-877
| -35% | -$36.8K | 0.06% | 110 |
|
|
2013
Q4 | $83K | Sell |
2,520
-1,135
| -31% | -$37.4K | 0.04% | 158 |
|
|
2013
Q3 | $99K | Buy |
+3,655
| New | +$99K | 0.05% | 138 |
|